Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
iStock Rating
F
Details...
Enter Symbol
GENOMIC HEALTH INC (NASDAQ: GHDX)
Sector: Medical
Current Price :
$37.00
52 Week Low
$26.42
52 Week High
$37.00
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
30M
Market Cap:
$0.90B
Avg Volume:
191184
P/E Ratio:
110.220
PEG Ratio:
186.580
Opinion and Analysis
Top Insider Purchases: DYAX, GHDX, OPK, NTS, SPB, WFR
May 17, 2013 11:57 AM |
DYAX
,
GHDX
,
WFR
Two Stocks For The Genetic-Based Cancer Test Market
Aug 18, 2012 03:20 PM |
GHDX
,
MYGN
Stellar Day For Stocks
Aug 16, 2012 09:07 PM |
AAPL
,
AMZN
,
BMTI
,
BTH
,
CCJ
,
CCRT
More Articles on GHDX..
Press Releases
Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 21, 2013 08:00 AM |
GHDX
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX? Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis
May 10, 2013 04:02 PM |
GHDX
Genomic Health Announces Availability of Oncotype DX? Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments
May 08, 2013 12:01 AM |
GHDX
More Press Releases on GHDX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
GHDX
Compare to S&P
YTD
9.25 %
0.19 %
4 Weeks
9.82 %
9.93 %
12 Weeks
2.69 %
-0.76 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-45.45 %
EPS Growth in Last Year:
-25.00 %
Sales Growth in Last Quarter:
3.04 %
Sales Growth in Last Quarter:
13.17 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##